EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso

Salam Sawadogo iD, Koumpingnin Nebie, Tieba Millogo, Sonia Sontie, Ashmed Nana, Honorine Dahourou, Dieudonné Yentema Yonli, Jean-Baptiste Tapko, Jean-Claude Faber, Eléonore Kafando, Véronique Deneys

Advances in Hematology · 20.12.2018 · 2018 · 1-9

DOI: 10.1155/2018/7938130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Hematology, erschienen am 20.12.2018. Verfasst von Salam Sawadogo und 10 weiteren Autor:innen. Beteiligte Einrichtung: University Ouaga I Professor Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traceability is an essential tool for haemovigilance and transfusion safety. In Burkina Faso, the implementation of haemovigilance has been achieved as part of a pilot project from 2005 to 2009. Our study aims to evaluate the traceability of blood transfusions and reporting of adverse reactions over the 6-year postpilot phase. A cross-sectional study including all blood units ordered between 2010 and 2015 has been conducted in public and private health care facilities supplied with blood products by the transfusion center of Bobo-Dioulasso. The complete traceability was possible for 83.5% of blood units delivered. Adverse reactions were reported in 107 cases representing 2.1/1,000 blood units per annum. Transfusions of wrong blood to wrong patient were reported in 13 cases. Our study shows that the haemovigilance system in Burkina Faso must be improved. Healthcare workers have to be sensitized on how traceability and haemovigilance could impact the quality of care provided to patients.

Autor:innen und Institutionen

  • University Ouaga I Professor Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
  • National Blood Transfusion Centre, 01 BP 5372 Ouagadougou, Burkina Faso.
  • African Institute of Public Health, 12 BP 199 Ouagadougou, Burkina Faso.
  • African Society for Blood Transfusion, Cameroon.
  • Association Luxembourgeoise des Hémophiles, 33 rue Albert Ier, 1117, Luxembourg.
  • CHU UCL Namur asbl, 15 place L. Godin, 5000 Namur, Belgium.

ORCID-Profile: Salam Sawadogo

Zitieren

APA

Sawadogo, S., Nebie, K., Millogo, T., Sontie, S., Nana, A., Dahourou, H., Yonli, D. Y., Tapko, J. B., Faber, J. C., Kafando, E., & Deneys, V. (2018). Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso. Advances in Hematology, 2018, 1-9. https://doi.org/10.1155/2018/7938130

Vancouver

Sawadogo S, Nebie K, Millogo T, Sontie S, Nana A, Dahourou H, et al. Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso. Advances in Hematology. 2018;2018:1-9. doi:10.1155/2018/7938130

BibTeX
@article{Sawadogo2018,
  author = {Sawadogo, Salam and Nebie, Koumpingnin and Millogo, Tieba and Sontie, Sonia and Nana, Ashmed and Dahourou, Honorine and Yonli, Dieudonné Yentema and Tapko, Jean-Baptiste and Faber, Jean-Claude and Kafando, Eléonore and Deneys, Véronique},
  title = {Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso},
  journal = {Advances in Hematology},
  year = {2018},
  volume = {2018},
  pages = {1--9},
  doi = {10.1155/2018/7938130}
}
Kostenlos starten →